nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS2—thyroid cancer	0.584	1	CbGaD
Lumiracoxib—UGT1A9—Sorafenib—thyroid cancer	0.237	0.644	CbGbCtD
Lumiracoxib—CYP2C19—Sorafenib—thyroid cancer	0.0477	0.129	CbGbCtD
Lumiracoxib—CYP1A2—Sorafenib—thyroid cancer	0.044	0.119	CbGbCtD
Lumiracoxib—CYP2C9—Sorafenib—thyroid cancer	0.0397	0.108	CbGbCtD
Lumiracoxib—PTGS1—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.00434	0.102	CbGpPWpGaD
Lumiracoxib—PTGS2—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.00345	0.0813	CbGpPWpGaD
Lumiracoxib—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.00326	0.077	CbGpPWpGaD
Lumiracoxib—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.00259	0.0611	CbGpPWpGaD
Lumiracoxib—PTGS1—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.00177	0.0418	CbGpPWpGaD
Lumiracoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT19—thyroid cancer	0.00154	0.0364	CbGpPWpGaD
Lumiracoxib—Bromfenac—PTGS2—thyroid cancer	0.00154	0.311	CrCbGaD
Lumiracoxib—PTGS2—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.00141	0.0332	CbGpPWpGaD
Lumiracoxib—PTGS1—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00118	0.0278	CbGpPWpGaD
Lumiracoxib—Tolmetin—PTGS2—thyroid cancer	0.00104	0.209	CrCbGaD
Lumiracoxib—Meclofenamic acid—PTGS2—thyroid cancer	0.00102	0.206	CrCbGaD
Lumiracoxib—UGT1A9—PPAR Alpha Pathway—CDK1—thyroid cancer	0.000949	0.0224	CbGpPWpGaD
Lumiracoxib—PTGS2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000936	0.0221	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000915	0.0216	CbGpPWpGaD
Lumiracoxib—UGT1A9—PPAR Alpha Pathway—RXRA—thyroid cancer	0.000881	0.0208	CbGpPWpGaD
Lumiracoxib—Mefenamic acid—PTGS2—thyroid cancer	0.000794	0.16	CrCbGaD
Lumiracoxib—UGT1A9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000746	0.0176	CbGpPWpGaD
Lumiracoxib—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00068	0.016	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—CHST14—thyroid cancer	0.000658	0.0155	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00062	0.0146	CbGpPWpGaD
Lumiracoxib—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—thyroid cancer	0.000585	0.0138	CbGpPWpGaD
Lumiracoxib—Diclofenac—PTGS2—thyroid cancer	0.00057	0.115	CrCbGaD
Lumiracoxib—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000529	0.0125	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000518	0.0122	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—PTGS2—thyroid cancer	0.000459	0.0108	CbGpPWpGaD
Lumiracoxib—UGT1A9—PPAR Alpha Pathway—CCND1—thyroid cancer	0.000395	0.00933	CbGpPWpGaD
Lumiracoxib—PTGS1—Eicosanoid Synthesis—PTGS2—thyroid cancer	0.00038	0.00897	CbGpPWpGaD
Lumiracoxib—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000351	0.00827	CbGpPWpGaD
Lumiracoxib—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00032	0.00754	CbGpPWpGaD
Lumiracoxib—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.000318	0.0075	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.000309	0.0073	CbGpPWpGaD
Lumiracoxib—PTGS1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000298	0.00703	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	0.000282	0.00665	CbGpPWpGaD
Lumiracoxib—UGT1A9—PPARA activates gene expression—RXRA—thyroid cancer	0.000278	0.00655	CbGpPWpGaD
Lumiracoxib—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	0.000272	0.00641	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—LGALS3—thyroid cancer	0.000268	0.00632	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—SLC5A5—thyroid cancer	0.000264	0.00622	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.000241	0.00569	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—RXRA—thyroid cancer	0.000222	0.00523	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—thyroid cancer	0.000213	0.00503	CbGpPWpGaD
Lumiracoxib—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000212	0.005	CbGpPWpGaD
Lumiracoxib—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000211	0.00499	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000207	0.00487	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—RXRA—thyroid cancer	0.000194	0.00458	CbGpPWpGaD
Lumiracoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000193	0.00456	CbGpPWpGaD
Lumiracoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000192	0.00454	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—NRG1—thyroid cancer	0.000192	0.00452	CbGpPWpGaD
Lumiracoxib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000187	0.00442	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CDK1—thyroid cancer	0.000183	0.00432	CbGpPWpGaD
Lumiracoxib—UGT1A9—PPARA activates gene expression—PPARG—thyroid cancer	0.000175	0.00414	CbGpPWpGaD
Lumiracoxib—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000172	0.00406	CbGpPWpGaD
Lumiracoxib—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.000172	0.00405	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000168	0.00397	CbGpPWpGaD
Lumiracoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000165	0.0039	CbGpPWpGaD
Lumiracoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000164	0.00388	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—RXRA—thyroid cancer	0.000158	0.00374	CbGpPWpGaD
Lumiracoxib—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000157	0.0037	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—MINPP1—thyroid cancer	0.000143	0.00337	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.00014	0.00329	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000135	0.00317	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000134	0.00316	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000134	0.00315	CbGpPWpGaD
Lumiracoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.000133	0.00313	CbGpPWpGaD
Lumiracoxib—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000122	0.00288	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NDUFA13—thyroid cancer	0.000121	0.00286	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.00012	0.00283	CbGpPWpGaD
Lumiracoxib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	0.000118	0.00279	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—MINPP1—thyroid cancer	0.000116	0.00275	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000116	0.00273	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CHST14—thyroid cancer	0.000114	0.00269	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000111	0.00262	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000102	0.00241	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000102	0.00239	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CCND1—thyroid cancer	0.0001	0.00236	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NDUFA13—thyroid cancer	9.9e-05	0.00233	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	9.71e-05	0.00229	CbGpPWpGaD
Lumiracoxib—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	9.5e-05	0.00224	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TRIM24—thyroid cancer	9.38e-05	0.00221	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CHST14—thyroid cancer	9.31e-05	0.00219	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—MINPP1—thyroid cancer	9.24e-05	0.00218	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—HPGD—thyroid cancer	9.2e-05	0.00217	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—RXRA—thyroid cancer	9.14e-05	0.00215	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.85e-05	0.00209	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CHST14—thyroid cancer	8.82e-05	0.00208	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	8.62e-05	0.00203	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TRIM33—thyroid cancer	8.36e-05	0.00197	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—RXRA—thyroid cancer	8.33e-05	0.00196	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	7.9e-05	0.00186	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NDUFA13—thyroid cancer	7.86e-05	0.00185	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	7.63e-05	0.0018	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.57e-05	0.00178	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—HPGD—thyroid cancer	7.5e-05	0.00177	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.46e-05	0.00176	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	7.42e-05	0.00175	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CHST14—thyroid cancer	7.39e-05	0.00174	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—RXRA—thyroid cancer	7.12e-05	0.00168	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	6.8e-05	0.0016	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—MINPP1—thyroid cancer	6.71e-05	0.00158	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	6.31e-05	0.00149	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MINPP1—thyroid cancer	6.12e-05	0.00144	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.08e-05	0.00143	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—HPGD—thyroid cancer	5.95e-05	0.0014	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	5.78e-05	0.00136	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NDUFA13—thyroid cancer	5.71e-05	0.00135	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TCF7L1—thyroid cancer	5.58e-05	0.00132	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CHST14—thyroid cancer	5.37e-05	0.00127	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—TPR—thyroid cancer	5.29e-05	0.00125	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MINPP1—thyroid cancer	5.23e-05	0.00123	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NDUFA13—thyroid cancer	5.2e-05	0.00123	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PRKAR1A—thyroid cancer	5.2e-05	0.00123	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	5.19e-05	0.00122	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	5.03e-05	0.00119	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	5.01e-05	0.00118	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CHST14—thyroid cancer	4.89e-05	0.00115	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.83e-05	0.00114	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.71e-05	0.00111	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NDUFA13—thyroid cancer	4.45e-05	0.00105	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—HPGD—thyroid cancer	4.32e-05	0.00102	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—TPR—thyroid cancer	4.31e-05	0.00102	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PRKAR1A—thyroid cancer	4.24e-05	0.001	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CHST14—thyroid cancer	4.18e-05	0.000986	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TPR—thyroid cancer	4.08e-05	0.000963	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PRKAR1A—thyroid cancer	4.02e-05	0.000947	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—SLC5A5—thyroid cancer	3.96e-05	0.000933	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HPGD—thyroid cancer	3.94e-05	0.00093	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.85e-05	0.000907	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.84e-05	0.000906	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MEN1—thyroid cancer	3.84e-05	0.000906	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.71e-05	0.000874	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.51e-05	0.000827	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—TPR—thyroid cancer	3.42e-05	0.000807	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.42e-05	0.000806	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HPGD—thyroid cancer	3.37e-05	0.000795	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PRKAR1A—thyroid cancer	3.36e-05	0.000794	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—RXRA—thyroid cancer	3.32e-05	0.000784	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.23e-05	0.000762	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—SLC5A5—thyroid cancer	3.23e-05	0.000761	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.2e-05	0.000754	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CALCA—thyroid cancer	3.06e-05	0.000721	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.05e-05	0.000719	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.02e-05	0.000713	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.89e-05	0.000681	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDK1—thyroid cancer	2.77e-05	0.000653	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.73e-05	0.000645	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—RXRA—thyroid cancer	2.71e-05	0.000639	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.64e-05	0.000622	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—SLC5A5—thyroid cancer	2.56e-05	0.000604	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—TPR—thyroid cancer	2.48e-05	0.000586	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	2.44e-05	0.000576	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—TPR—thyroid cancer	2.26e-05	0.000534	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	2.23e-05	0.000525	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NRG1—thyroid cancer	2.22e-05	0.000524	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.21e-05	0.000522	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—RXRA—thyroid cancer	2.15e-05	0.000507	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PPARG—thyroid cancer	2.1e-05	0.000495	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.09e-05	0.000493	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.02e-05	0.000476	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TERT—thyroid cancer	1.99e-05	0.00047	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—TPR—thyroid cancer	1.94e-05	0.000456	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HIF1A—thyroid cancer	1.91e-05	0.00045	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.9e-05	0.000449	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.86e-05	0.000439	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.74e-05	0.000411	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.73e-05	0.000407	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PPARG—thyroid cancer	1.71e-05	0.000403	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.7e-05	0.0004	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS2—thyroid cancer	1.65e-05	0.000389	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.59e-05	0.000375	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—BRAF—thyroid cancer	1.58e-05	0.000372	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—RXRA—thyroid cancer	1.56e-05	0.000368	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.52e-05	0.000358	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.45e-05	0.000342	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTEN—thyroid cancer	1.44e-05	0.00034	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—RXRA—thyroid cancer	1.42e-05	0.000336	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.39e-05	0.000327	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PPARG—thyroid cancer	1.36e-05	0.00032	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.36e-05	0.00032	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGS2—thyroid cancer	1.35e-05	0.000317	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—RXRA—thyroid cancer	1.22e-05	0.000287	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.18e-05	0.000279	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTEN—thyroid cancer	1.17e-05	0.000277	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PTEN—thyroid cancer	1.11e-05	0.000262	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NRAS—thyroid cancer	9.93e-06	0.000234	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PPARG—thyroid cancer	9.86e-06	0.000233	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PTEN—thyroid cancer	9.32e-06	0.00022	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PPARG—thyroid cancer	8.99e-06	0.000212	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—KRAS—thyroid cancer	8.54e-06	0.000201	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—AKT1—thyroid cancer	8.3e-06	0.000196	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS2—thyroid cancer	7.76e-06	0.000183	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PPARG—thyroid cancer	7.69e-06	0.000181	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HRAS—thyroid cancer	7.26e-06	0.000171	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS2—thyroid cancer	7.08e-06	0.000167	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTEN—thyroid cancer	6.77e-06	0.00016	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AKT1—thyroid cancer	6.76e-06	0.00016	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKT1—thyroid cancer	6.41e-06	0.000151	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTEN—thyroid cancer	6.17e-06	0.000146	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS2—thyroid cancer	6.05e-06	0.000143	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AKT1—thyroid cancer	5.37e-06	0.000127	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTEN—thyroid cancer	5.27e-06	0.000124	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AKT1—thyroid cancer	3.9e-06	9.2e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AKT1—thyroid cancer	3.56e-06	8.39e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AKT1—thyroid cancer	3.04e-06	7.17e-05	CbGpPWpGaD
